ALS Reversals: New Paths
Dr. Bedlack’s team studies Amyotrophic Lateral Sclerosis (ALS) reversals to understand why a few people regain function. The St.A.R. program looks back for clues, while R.O.A.R. tests reversal-linked therapies in small, open trials. New work on the gut with microbiota transplant therapy (FMT) and a beta-Hydroxy beta-Methylbutyrate (HMB) supplement seeks personalized paths to slow or reverse ALS, guided by science and hope.
Article#Dr. Bedlack#Hope#Amyotrophic Lateral Sclerosis (ALS)#Motor Neurone Disease (MND)